1mg, best e pharmacy in India


MRP: Rs. 461.75 for 1 vial(s) (0.4 ML injection each)
Unfortunately, we don't have any more items in stock
Report Error

Composition for FRAXIPARINE

Nadroparin(3800 IU/0.4ml)

food interaction for FRAXIPARINE

alcohol interaction for FRAXIPARINE

pregnancy interaction for FRAXIPARINE

lactation interaction for FRAXIPARINE

It can be taken with or without food, but it is better to take Fraxiparine 3800 iu/0.4ml injection at a fixed time.
Avoid Fraxiparine 3800 iu/0.4ml injection with valerian, kava kava and gotu kola.
Interaction with alcohol is unknown. Please consult your doctor.
Fraxiparine 3800 iu/0.4ml injection is probably safe to use during pregnancy.
Either animal studies have shown no adverse effect on the fetus, but there is no human studies or animal studies have shown an adverse effect that was not confirmed in human studies. Please consult your doctor.
Unknown. Human and animal studies are not available. Please consult your doctor.


Nadroparin(3800 IU/0.4ml)


Fraxiparine 3800 iu/0.4ml injection is used to prevent and treat deep vein thrombosis (a condition in which harmful blood clots form in the blood vessels of the legs, which can travel and become lodged in the blood vessels of the lungs, causing pulmonary embolism). Fraxiparine 3800 iu/0.4ml injection is also is used to treat unstable angina or certain types of heart attacks and to prevent blood clots from forming during hemodialysis.

How it works

Fraxiparine 3800 iu/0.4ml injection belongs to a group of medicines called as low molecular weight heparins (LMWHs).It works by halting the coagulation pathway of thrombin and fibrin clotting cascade, thereby preventing clot formation.

Common side effects

Injection site hematoma


No substitutes found

Expert advice for FRAXIPARINE

  • Inform your doctor if you have liver disease, kidney disease or gastrointestinal ulceration.
  • You may need to regularly check and monitor for anti-factor Xa concentration, plasma and hemoglobin concentration and International Normalized Ratio (INR) during treatment with Nadroparin.
  • Your platelet counts should be determined prior to the commencement of therapy and twice a week for the duration of Nadroparin therapy.
  • Discontinue Nadroparin and seek immediate medical attention if you suffer from thrombocytopenia (deficiency of platelets in the blood).
  • Nadroparin may interfere with certain laboratory tests like liver function tests.
  • Inform your doctor if you are taking any medications such as aspirin or other drugs to reduce blood clotting such as warfarin.
  • Tell your doctor if you are pregnant, planning to become pregnant or are breastfeeding.


Content on this page was last updated on 26 May, 2015, by Dr. Varun Gupta (MD Pharmacology)